Core Laboratories Inc.
CLB
$12.65
$0.131.04%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -44.00% | -412.34% | -33.16% | 21.23% | 17.76% |
| Total Depreciation and Amortization | 4.22% | 1.26% | 0.11% | -2.23% | -2.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 229.48% | -68.46% | 830.46% | -397.31% | 42.35% |
| Change in Net Operating Assets | -352.57% | 68.99% | -185.33% | -241.72% | -76.37% |
| Cash from Operations | -43.91% | -40.47% | -61.46% | -35.08% | -18.80% |
| Capital Expenditure | -33.27% | -36.66% | 16.64% | -11.03% | -51.01% |
| Sale of Property, Plant, and Equipment | 63.87% | 21.22% | -16.71% | 14.29% | 364.42% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -89.12% | -99.71% | -840.00% | 150.40% | 18.47% |
| Cash from Investing | -139.11% | -539.25% | -5.42% | 587.37% | -139.30% |
| Total Debt Issued | 25.00% | 407.69% | 100.00% | -31.25% | 50.00% |
| Total Debt Repaid | -30.21% | -313.33% | 20.00% | 16.67% | 42.86% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 1.75% | -97.68% | 45.84% | -2,455.61% | -1,590.74% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 1.92% | 1.92% | 0.64% | 0.85% | 0.21% |
| Other Financing Activities | -1,960.00% | -- | -- | -1,122.22% | 122.22% |
| Cash from Financing | -23.89% | 89.80% | 63.24% | -86.41% | 76.62% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -100.93% | -96.03% | -26.33% | -247.10% | 226.42% |